Literature DB >> 15060211

A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses.

Andrea S Hinkle1, Cindy Proukou, Carol A French, Amy M Kozlowski, Louis S Constine, Stuart R Lipsitz, Tracie L Miller, Steve E Lipshultz.   

Abstract

OBJECTIVE: Long-term survivors of several childhood illnesses are at risk for multiple late effects of their illness or therapy, and children with documented toxic exposures may also experience long-term health consequences. Clinical studies of these effects are difficult to conduct. The Cardiovascular Status in Childhood Cancer Survivors Study is an established study that highlights the ability to perform comprehensive clinical investigations when patients are cared for in a formal, long-term follow-up clinic. This clinic model facilitates long-term retention and recruitment of patients, allowing comprehensive clinical studies of late effects of illness or exposures, in this case, of cardiovascular complications of cancer treatment during childhood.
METHODS: The study is funded through the National Institute of Health Office of Cancer Survivorship. Participants are recruited from the Long-Term Survivors Clinic at the University of Rochester. The clinic provides care for all survivors of childhood cancer in the region. The Long-Term Survivors Clinic provides medical care and psychosocial and educational support to patients and facilitates coordination of care. Patients remain in close contact with clinic staff for extended periods.
RESULTS: We recruited a representative sample of this long-term survivor population, with a wide range of ages, diagnoses, and time since diagnosis. Longitudinal collection of detailed clinical data will enable us to conduct cohort studies of late effects as well as case-control studies of toxic exposures.
CONCLUSIONS: The success of this study shows the advantages of formal programs for continued care of patients with chronic illnesses or treatment or toxic exposures. The Long-Term Survivors Clinic provides an excellent model for clinical care and research that is applicable to multiple pediatric and young adult populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060211

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Why multidisciplinary clinics should be the standard for treating chronic kidney disease.

Authors:  Guido Filler; Steven E Lipshultz
Journal:  Pediatr Nephrol       Date:  2012-07-04       Impact factor: 3.714

2.  Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.

Authors:  David C Landy; Tracie L Miller; Gabriela Lopez-Mitnik; Stuart R Lipsitz; Andrea S Hinkle; Louis S Constine; Carol A French; Amy M K Rovitelli; M Jacob Adams; Steven E Lipshultz
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

3.  Characteristics and determinants of adiposity in pediatric cancer survivors.

Authors:  Tracie L Miller; Stuart R Lipsitz; Gabriela Lopez-Mitnik; Andrea S Hinkle; Louis S Constine; M Jacob Adams; Carol French; Cynthia Proukou; Amy Rovitelli; Steven E Lipshultz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

4.  An investigation of survivorship clinic attendance among childhood cancer survivors living in a five-state rural region.

Authors:  Judy Y Ou; Rochelle R Smits-Seemann; Yelena P Wu; Jennifer Wright; Anne C Kirchhoff
Journal:  J Cancer Surviv       Date:  2017-11-29       Impact factor: 4.442

5.  Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.

Authors:  Steven E Lipshultz; David C Landy; Gabriela Lopez-Mitnik; Stuart R Lipsitz; Andrea S Hinkle; Louis S Constine; Carol A French; Amy M Rovitelli; Cindy Proukou; M Jacob Adams; Tracie L Miller
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

Review 6.  Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.

Authors:  Danielle Harake; Vivian I Franco; Jacqueline M Henkel; Tracie L Miller; Steven E Lipshultz
Journal:  Future Cardiol       Date:  2012-07

Review 7.  Cardiotoxicity of cancer chemotherapy: implications for children.

Authors:  Valeriano C Simbre; Sarah A Duffy; Gul H Dadlani; Tracie L Miller; Steven E Lipshultz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

Review 8.  Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

Authors:  Leslie L Robison; Melissa M Hudson
Journal:  Nat Rev Cancer       Date:  2013-12-05       Impact factor: 60.716

9.  Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study.

Authors:  David C Landy; Tracie L Miller; Stuart R Lipsitz; Gabriela Lopez-Mitnik; Andrea S Hinkle; Louis S Constine; M Jacob Adams; Steven E Lipshultz
Journal:  Pediatr Cardiol       Date:  2012-10-19       Impact factor: 1.655

10.  NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.

Authors:  Amal Zidan; Laila M Sherief; Amera El-sheikh; Safaa H Saleh; Doaa A Shahbah; Naglaa M Kamal; Hanan S Sherbiny; Heba Ahmad
Journal:  Dis Markers       Date:  2015-04-16       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.